1 |
Swain S M, Shastry M, Hamilton E. Targeting HER2-positive breast cancer: advances and future directions[J]. Nature Reviews Drug Discovery, 2023, 22(2): 101-126.
|
2 |
Briani C, Visentin A. Therapeutic monoclonal antibody therapies in chronic autoimmune demyelinating neuropathies[J]. Neurotherapeutics: the Journal of the American Society for Experimental Neuro Therapeutics, 2022, 19(3): 874-884.
|
3 |
Saoudi Gonzalez N, López D, Gómez D, et al. Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer[J]. Expert Opinion on Drug Metabolism & Toxicology, 2022, 18(11): 755-767.
|
4 |
Khanal O, Lenhoff A M. Developments and opportunities in continuous biopharmaceutical manufacturing[J]. mAbs, 2021, 13(1): 1903664.
|
5 |
史策, 虞骥, 高栋, 等. 单抗制备的过程模拟和经济性分析[J]. 化工学报, 2018, 69(7): 3198-3207.
|
|
Shi C, Yu J, Gao D, et al. Process simulation and economic evaluation of monoclonal antibody production[J]. CIESC Journal, 2018, 69(7): 3198-3207.
|
6 |
卢慧丽, 林东强, 姚善泾. 抗体药物分离纯化中的层析技术及进展[J]. 化工学报, 2018, 69(1): 341-351.
|
|
Lu H L, Lin D Q, Yao S J. Chromatographic technology in antibody purification and its progress[J]. CIESC Journal, 2018, 69(1): 341-351.
|
7 |
陈泉, 卓燕玲, 许爱娜, 等. 蛋白A亲和层析法纯化单克隆抗体工艺的优化[J]. 生物工程学报, 2016, 32(6): 807-818.
|
|
Chen Q, Toh P, Hoi A, et al. Improved protein-A chromatography for monoclonal antibody purification[J]. Chinese Journal of Biotechnology, 2016, 32(6): 807-818.
|
8 |
鲁伟, 应国清, 杨晓明, 等. 单克隆抗体工业生产中蛋白A亲和层析步骤的成本分析[J]. 高校化学工程学报, 2023, 37(2): 276-284.
|
|
Lu W, Ying G Q, Yang X M, et al. Cost analysis of protein A affinity chromatography in industrial production of monoclonal antibody[J]. Journal of Chemical Engineering of Chinese Universities, 2023, 37(2): 276-284.
|
9 |
荆淑莹, 史策, 姚善泾, 等. 连续流层析及用于抗体分离的新进展[J]. 高校化学工程学报, 2021, 35(1): 1-12.
|
|
Jing S Y, Shi C, Yao S J, et al. Progress on continuous chromatography and its application in antibody separation[J]. Journal of Chemical Engineering of Chinese Universities, 2021, 35(1): 1-12.
|
10 |
Hari S B, Lau H, Razinkov V I, et al. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition[J]. Biochemistry, 2010, 49(43): 9328-9338.
|
11 |
Liu H F, Ma J F, Winter C, et al. Recovery and purification process development for monoclonal antibody production[J]. mAbs, 2010, 2(5): 480-499.
|
12 |
Arosio P, Barolo G, Müller-Späth T, et al. Aggregation stability of a monoclonal antibody during downstream processing[J]. Pharmaceutical Research, 2011, 28(8): 1884-1894.
|
13 |
Joshi V, Yadav N, Rathore A. Aggregation of monoclonal antibody products: formation and removal[J]. BioPharm International, 2013, 26(3): 40-45.
|
14 |
Rosenberg A S. Effects of protein aggregates: an immunologic perspective[J]. The AAPS Journal, 2006, 8(3): 59.
|
15 |
Cromwell M E M, Hilario E, Jacobson F. Protein aggregation and bioprocessing[J]. The AAPS Journal, 2006, 8(3): 66.
|
16 |
Moussa E M, Panchal J P, Moorthy B S, et al. Immunogenicity of therapeutic protein aggregates[J]. Journal of Pharmaceutical Sciences, 2016, 105(2): 417-430.
|
17 |
Vázquez-Rey M, Lang D A. Aggregates in monoclonal antibody manufacturing processes[J]. Biotechnology and Bioengineering, 2011, 108(7): 1494-1508.
|
18 |
Shukla A A, Hubbard B, Tressel T, et al. Downstream processing of monoclonal antibodies—application of platform approaches[J]. Journal of Chromatography B, 2007, 848(1): 28-39.
|
19 |
Lu Y F, Williamson B, Gillespie R. Recent advancement in application of hydrophobic interaction chromatography for aggregate removal in industrial purification process[J]. Current Pharmaceutical Biotechnology, 2009, 10(4): 427-433.
|
20 |
McCue J T. Chapter 25 theory and use of hydrophobic interaction chromatography in protein purification applications[M]//Burgess R R, Deutscher M P. Methods in Enzymology. 2nd ed. Amsterdam: Elsevier, 2009: 405-414.
|
21 |
McCue J T, Engel P, Ng A, et al. Modeling of protein monomer/aggregate purification and separation using hydrophobic interaction chromatography[J]. Bioprocess and Biosystems Engineering, 2008, 31(3): 261-275.
|
22 |
Ichihara T, Ito T, Kurisu Y, et al. Integrated flow-through purification for therapeutic monoclonal antibodies processing[J]. mAbs, 2018, 10(2): 325-334.
|
23 |
Liu H F, McCooey B, Duarte T, et al. Exploration of overloaded cation exchange chromatography for monoclonal antibody purification[J]. Journal of Chromatography A, 2011, 1218(39): 6943-6952.
|
24 |
Reck J M, Pabst T M, Hunter A K, et al. Separation of antibody monomer-dimer mixtures by frontal analysis[J]. Journal of Chromatography A, 2017, 1500: 96-104.
|
25 |
Wollacott R, Roth L, Sears T, et al. The development of a flow-through mode cation exchange process for the purification of a monoclonal antibody[J]. BioProcessing Journal, 2015, 14(2): 5-13.
|
26 |
Stone M T, Cotoni K A, Stoner J L. Cation exchange frontal chromatography for the removal of monoclonal antibody aggregates[J]. Journal of Chromatography A, 2019, 1599: 152-160.
|
27 |
Vogg S, Pfeifer F, Ulmer N, et al. Process intensification by frontal chromatography: performance comparison of resin and membrane adsorber for monovalent antibody aggregate removal[J]. Biotechnology and Bioengineering, 2020, 117(3): 662-672.
|
28 |
Wolf M K F, Closet A, Bzowska M, et al. Improved performance in mammalian cell perfusion cultures by growth inhibition[J]. Biotechnology Journal, 2019, 14(2): 1700722.
|
29 |
Reck J M, Pabst T M, Hunter A K, et al. Adsorption equilibrium and kinetics of monomer-dimer monoclonal antibody mixtures on a cation exchange resin[J]. Journal of Chromatography A, 2015, 1402: 46-59.
|
30 |
Carta G, Jungbauer A. Downstream processing of biotechnology products[M]//Protein Chromatography. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2010: 1-55.
|